TY - JOUR
T1 - Alterations in Early Filling Dynamics Predict the Progression of Compensated Pressure Overload Hypertrophy to Heart Failure Better than Abnormalities in Midwall Systolic Shortening
AU - Perlini, Stefano
AU - Chung, Eugene S.
AU - Aurigemma, Gerard P.
AU - Meyer, Theo E.
PY - 2013
Y1 - 2013
N2 - To evaluate whether the evolution of compensated pressure overload hypertrophy (POH) to overt heart failure (HF) is better predicted by systolic versus diastolic dysfunction, serial echocardiography was performed 1, 2, 4, 8, and 10 weeks after suprarenal aortic banding in 52 rats. One week after banding, at comparable extent of left ventricular hypertrophy and geometry, myocardial and chamber systolic performance, a restrictive filling pattern was well evident only in rats which eventually developed overt HF, according to postmortem lung weight. In experimental POH, early assessment of transmitral flow velocity allows to predict a faster progression toward HF.
AB - To evaluate whether the evolution of compensated pressure overload hypertrophy (POH) to overt heart failure (HF) is better predicted by systolic versus diastolic dysfunction, serial echocardiography was performed 1, 2, 4, 8, and 10 weeks after suprarenal aortic banding in 52 rats. One week after banding, at comparable extent of left ventricular hypertrophy and geometry, myocardial and chamber systolic performance, a restrictive filling pattern was well evident only in rats which eventually developed overt HF, according to postmortem lung weight. In experimental POH, early assessment of transmitral flow velocity allows to predict a faster progression toward HF.
KW - Diastolic function
KW - Echocardiography
KW - Heart failure
KW - Hypertrophy
KW - Systolic function
KW - Transition
UR - http://www.scopus.com/inward/record.url?scp=84884549821&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84884549821&partnerID=8YFLogxK
U2 - 10.3109/10641963.2012.739235
DO - 10.3109/10641963.2012.739235
M3 - Article
C2 - 23134254
AN - SCOPUS:84884549821
SN - 1064-1963
VL - 35
SP - 401
EP - 411
JO - Clinical and Experimental Hypertension
JF - Clinical and Experimental Hypertension
IS - 6
ER -